Door-to-balloon Time for ST-elevation MI in the Coronavirus Disease 2019 Era

In patients presenting with ST-elevation MI, prompt primary coronary intervention is the preferred treatment modality. Several studies have described improved outcomes in patients with door-to-balloon (D2B) and symptom onset-to-balloon (OTB) times of less than 2 hours, but the specific implications...

Full description

Saved in:
Bibliographic Details
Main Authors: Haytham Mously, Nischay Shah, Zachary Zuzek, Ibrahim Alshaghdali, Adham Karim, Rahul Jaswaney, Steven J Filby, Daniel I Simon, Mehdi H Shishehbor, Farshad Forouzandeh
Format: article
Language:EN
Published: Radcliffe Medical Media 2021
Subjects:
Online Access:https://doaj.org/article/36d61c27da4e4f0b83c620b367cbc864
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In patients presenting with ST-elevation MI, prompt primary coronary intervention is the preferred treatment modality. Several studies have described improved outcomes in patients with door-to-balloon (D2B) and symptom onset-to-balloon (OTB) times of less than 2 hours, but the specific implications of the coronavirus disease 2019 (COVID-19) pandemic on D2B and OTB times are not well-known. This review aims to evaluate the impact of COVID-19 on D2B time and elucidate both the factors that delay D2B time and strategies to improve D2B time in the contemporary era. The search was directed to identify articles discussing the significance of D2B times before and during COVID-19, from the initialization of the database to December 1, 2020. The majority of studies found that onset-of-symptom to hospital arrival time increased in the COVID-19 era, whereas D2B time and mortality were unchanged in some studies and increased in others.